More than half of cancer survivors have underlying medical conditions associated with severe COVID

February 03, 2021

ATLANTA - FEBRUARY 3, 2021 - New study finds more than half (56.4%) of cancer survivors in the United States reported having additional underlying medical conditions associated with severe COVID-19 illness. The report appearing in JNCI: The Journal of the National Cancer Institute, suggests that prevalence of these conditions among cancer survivors is nearly 40% higher than that in the general population.

Cancer, and other underlying medical conditions, including chronic obstructive pulmonary disease, heart diseases, diabetes, chronic kidney disease, and obesity, are associated with increased risk of severe COVID-19 illness. For this study, investigators Changchuan (Charles) Jiang, MD, PhD, Roswell Park Comprehensive Cancer Center, Xuesong Han, PhD, American Cancer Society, and colleagues used data from the 2016-2018 National Health Interview Survey (NHIS), a national cross-sectional survey of the civilian, noninstitutionalized population, to examine the prevalence of underlying medical conditions associated with severe COVID-19 Illness in adult cancer survivors in the U.S.

"This study investigates the prevalence and factors associated with these underlying medical conditions among cancer survivors in the U.S. We felt it was important to compile and analyze the available data to inform the public and guide the policy makers on opportunities to prevent and control severe COVID-19-associated illness through strategies such as risk-stratified vaccine distribution," said Dr. Jiang.

Most cancer survivors reported having more than one of the conditions associated with severe COVID-19 illness and nearly one-quarter reported more than two conditions. These conditions were more prevalent in survivors of kidney, liver and uterine cancers, as well as Black survivors, those with low socioeconomic status, and public insurance.

Older age was associated with higher prevalence of medical conditions among cancer survivors and adults without a cancer history. However, even in the youngest age group (18 to 44 years), nearly half of cancer survivors (47.6%) had at least one additional condition associated with severe COVID-19 illness. In addition to increasing prevalence with age, medical conditions were more prevalent among male survivors (59.9%), those with less than high school completion (68.0%), non-Hispanic Black (67.2%), low income (71.7%), and those living in the South (59.2%).

"The findings highlight the need to protect survivors against COVID-19 transmission and to prioritize cancer survivors in vaccine allocation," said Dr. Han.
Article: Jiang C, Yabroff KR, Deng L, Perimbeti S, Han X. Prevalence of Underlying Medical Conditions Associated with Severe COVID-19 Illness in Adult Cancer Survivors in the United States. JNCI: The Journal of the National Cancer Institute, 2021. doi: 10.1093/jnci/djab012.

URL upon embargo:

American Cancer Society

Related Cancer Articles from Brightsurf:

New blood cancer treatment works by selectively interfering with cancer cell signalling
University of Alberta scientists have identified the mechanism of action behind a new type of precision cancer drug for blood cancers that is set for human trials, according to research published in Nature Communications.

UCI researchers uncover cancer cell vulnerabilities; may lead to better cancer therapies
A new University of California, Irvine-led study reveals a protein responsible for genetic changes resulting in a variety of cancers, may also be the key to more effective, targeted cancer therapy.

Breast cancer treatment costs highest among young women with metastic cancer
In a fight for their lives, young women, age 18-44, spend double the amount of older women to survive metastatic breast cancer, according to a large statewide study by the University of North Carolina at Chapel Hill.

Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.

Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.

Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.

Moffitt Cancer Center researchers identify one way T cell function may fail in cancer
Moffitt Cancer Center researchers have discovered a mechanism by which one type of immune cell, CD8+ T cells, can become dysfunctional, impeding its ability to seek and kill cancer cells.

More cancer survivors, fewer cancer specialists point to challenge in meeting care needs
An aging population, a growing number of cancer survivors, and a projected shortage of cancer care providers will result in a challenge in delivering the care for cancer survivors in the United States if systemic changes are not made.

New cancer vaccine platform a potential tool for efficacious targeted cancer therapy
Researchers at the University of Helsinki have discovered a solution in the form of a cancer vaccine platform for improving the efficacy of oncolytic viruses used in cancer treatment.

American Cancer Society outlines blueprint for cancer control in the 21st century
The American Cancer Society is outlining its vision for cancer control in the decades ahead in a series of articles that forms the basis of a national cancer control plan.

Read More: Cancer News and Cancer Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to